23 insiders reported 115 Form 4 transactions for Acrivon Therapeutics, Inc. (ACRV) over the past 18 months (most recent 2026-09-02). Recent activity: Levin Michaela (Chief Business Officer) Buy 30,000 shares, Blume-Jensen Peter (President and CEO) Sell 14,036 shares, Masson Kristina (EVP - Business Operations) Sell 14,036 shares, Miller Mary (Chief Legal Officer) Sell 185 shares, Blume-Jensen Peter (President and CEO) Sell 1,229 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | Levin Michaela | Chief Business Officer | Buy | 30,000 | $0 |
| 2026-08-27 | Blume-Jensen Peter | President and CEO | Sell | 14,036 | $30,969 |
| 2026-08-27 | Masson Kristina | EVP - Business Operations | Sell | 14,036 | $30,969 |
| 2026-08-20 | Miller Mary | Chief Legal Officer | Sell | 185 | $372 |
| 2026-08-20 | Blume-Jensen Peter | President and CEO | Sell | 1,229 | $2,470 |
| 2026-08-20 | Masson Kristina | EVP - Business Operations | Sell | 1,229 | $2,470 |
| 2026-08-20 | Gamelin Erick | Chief Development Officer | Sell | 400 | $804 |
| 2026-08-20 | Devroe Eric | Chief Operating Officer | Sell | 604 | $1,214 |
| 2026-08-20 | Peterson Katharine | Chief Accounting Officer | Sell | 101 | $203 |
| 2026-08-20 | Blume-Jensen Peter | President and CEO | Sell | 484 | $973 |
| 2026-08-20 | Masson Kristina | EVP - Business Operations | Sell | 484 | $973 |
| 2026-08-06 | Levy Adam D. | Chief Financial Officer | Sell | 1,142 | $1,793 |
| 2026-07-23 | Miller Mary | Chief Legal Officer | Sell | 573 | $1,008 |
| 2026-05-26 | Blume-Jensen Peter | President and CEO | Sell | 13,729 | $24,575 |
| 2026-05-26 | Masson Kristina | EVP - Business Operations | Sell | 13,729 | $24,575 |
| 2026-05-20 | TOMSICEK MICHAEL JOHN | Director | Buy | 9,366 | $0 |
| 2026-05-20 | Palani Santhosh | Director | Buy | 9,366 | $0 |
| 2026-05-20 | Levy Adam D. | Chief Financial Officer | Buy | 46,167 | $0 |
| 2026-05-20 | Miller Mary | Chief Legal Officer | Buy | 49,830 | $0 |
| 2026-05-20 | Magovcevic-Liebisch Ivana | Director | Buy | 9,366 | $0 |
| 2026-05-20 | RA Capital Healthcare Fund LP | Director | Buy | 9,366 | $0 |
| 2026-05-20 | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 9,366 | $0 |
| 2026-05-20 | Kolchinsky Peter | Director | Buy | 9,366 | $0 |
| 2026-05-20 | Shah Rajeev M. | Director | Buy | 9,366 | $0 |
| 2026-05-20 | RA Capital Nexus Fund II, L.P. | Director | Buy | 9,366 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-02